Jones Financial Companies
CTKB icon

Jones Financial Companies’s Cytek Biosciences CTKB Stock Holding History

Jones Financial Companies’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14K Hold
254
– – ﹤0.01% 4579
2026
Q1 		$1.1K Hold
254
– – ﹤0.01% 4326
2025
Q4 		$1.28K Hold
254
– – ﹤0.01% 3959
2025
Q3 		$864 Hold
254
– – ﹤0.01% 3928
2025
Q2 		$902 Buy
+254
New +$846 ﹤0.01% 3680

Other funds holding CTKB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jones Financial Companies's CTKB Position: Q2 2026 in Review

Jones Financial Companies held its Cytek Biosciences (CTKB) position steady in Q2 2026 at 254 shares worth $1.14K. The position accounts for ﹤0.01% of the portfolio, ranked #4579.

Jones Financial Companies first reported a position in CTKB in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.28K in Q4 2025. 154 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • Jones Financial Companies held 254 shares of Cytek Biosciences worth $1.14K as of Q2 2026.
  • Jones Financial Companies left its Cytek Biosciences share count unchanged in Q2 2026.
  • Cytek Biosciences made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4579 holding.
  • Jones Financial Companies first reported a position in Cytek Biosciences in Q2 2025 and has held it in 5 quarters since.
  • Jones Financial Companies's Cytek Biosciences position peaked at $1.28K in Q4 2025.
  • 154 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.